Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Satellos Bioscience Inc (QB) | MSCLF | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.32 | 13:40:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.32 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.22046 - 0.5701 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.32 | USD |
Satellos Bioscience Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 50.76M | 112.79M | 180.08M | 0 | -15.89M | -0.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Satellos Bioscience (QB) News
Real-Time news about Satellos Bioscience Inc (QB) (OTCMarkets): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MSCLF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.33 | 0.35 | 0.2974 | 0.3217961 | 31,220 | -0.01 | -3.03% |
| 1 Month | 0.4576 | 0.4576 | 0.2974 | 0.3516176 | 27,124 | -0.1376 | -30.07% |
| 3 Months | 0.4137 | 0.5701 | 0.2974 | 0.3897069 | 15,276 | -0.0937 | -22.65% |
| 6 Months | 0.2563 | 0.5701 | 0.22046 | 0.3759992 | 17,096 | 0.0637 | 24.85% |
| 1 Year | 0.48 | 0.5701 | 0.22046 | 0.3819803 | 16,321 | -0.16 | -33.33% |
| 3 Years | 0.928 | 1.00 | 0.0035 | 0.3869435 | 15,104 | -0.608 | -65.52% |
| 5 Years | 0.928 | 1.00 | 0.0035 | 0.3869435 | 15,104 | -0.608 | -65.52% |
Satellos Bioscience (QB) Description
| Satellos is a biotechnology company dedicated to developing life-changing medicines to treat degenerative muscle conditions. Satellos' lead program is focused on developing an oral therapeutic drug intended to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. This therapeutic approach represents a potential disease modifying treatment for Duchenne and other dystrophies, offering new hope to patients. To expand programs to other degenerative muscle conditions or disorders, Satellos has created a proprietary discovery platform, MyoReGenX, which is utilized to identify disease situations where deficits in muscle stem cell polarity and regeneration occur and are amenable to therapeutic treatment. |
